Health Supernova 2022 Health Supernova 2022
Get your ticket to attend. Join event to build your agenda.

Lightning Talk | Platform Approaches to Combating Diseases

- CDT
Room 104B

Benjamin M. Greenberg
UT Southwestern, Professor of Neurology

Dr. Benjamin Greenberg received his Bachelor of Arts degree from Johns Hopkins University and his Master's Degree in Molecular Microbiology and Immunology from the Johns Hopkins School of Public Health in Baltimore, Maryland. He attended medical school at Baylor College of Medicine in Houston, Texas. Then, he completed an internship in medicine at Rush Presbyterian-St. Lukes Medical Center in Chicago, Illinois before going on to his residency in neurology at The Johns Hopkins Hospital in Baltimore, MD. He then joined the faculty within the division of neuroimmunology at Hopkins and became the co-director of the Transverse Myelitis Center and director of the Encephalitis Center. In January of 2009, he was recruited to the faculty at the University of Texas Southwestern Medical Center where he was named Deputy Director of the Multiple Sclerosis Program and Director of the new Transverse Myelitis and Neuromyelitis Optica Program. That same year he established the Pediatric Demyelinating Disease Program at Children’s Medical Center Dallas.

Dr. Greenberg is recognized internationally as an expert in rare autoimmune disorders of the central nervous system (e.g. transverse myelitis, neuromyelitis optica, ADEM, and autoimmune encephalitis). He splits his clinical time between seeing both adult and pediatric patients. He routinely consults on the inpatient units of University Hospital, Zale Lipshy, Parkland, and Children’s. His research interests are in both the diagnosis and treatment of transverse myelitis, neuromyelitis optica, encephalitis, multiples sclerosis, and infections of the nervous system. He is actively involved in developing better ways to diagnose and prognosticate for patients with these disorders. He has led an effort to improve biorepository development and has created uniform protocols for sample handling and analysis. As part of this initiative, his research has identified novel biomarkers that may be able to distinguish between patients with various neurologic disorders. He also coordinates trials that study new treatments to prevent neurologic damage and restore function to those who have already been affected. He currently serves as the Director of the Perot Foundation Neurosciences Translational Research Center and is a Cain Denius Foundation Scholar in Mobility Disorders.

David Greenberg
UT Southwestern, Professor, Infectious Diseases and Microbiology

David is Professor of Infectious Diseases and Microbiology at UT Southwestern Medical Center and a Distinguished Teaching Professor. He received his Infectious Diseases training at NIH and served as a faculty member within NIAID. A native Texan, David was recruited back to his home state and joined the faculty at UT Southwestern in 2010. He is a multiyear NIH-funded physician-scientist and is performing cutting edge science across a number of Infectious Disease related domains. His research interests revolve around the increasing crisis of antibiotic resistance. He is actively involved in developing innovative strategies to develop new therapeutics to combat drug-resistant infections. The lab is developing species-specific antibiotics utilizing antisense molecules that remain active in extremely drug-resistant pathogens as well as in the biofilm setting. In addition, he is working to merge rapid sequencing and machine learning techniques to more accurately predict antibiotic resistance in medically important human pathogens. He is widely published and is nationally known for his research. He serves as a reviewer for numerous Infectious Diseases publications, an author for one of the leading Infectious Diseases textbooks and a longstanding member of a NIH Infectious Disease therapeutics study section.


What began as endless battles with action figures is now an endless and inspiring crusade to prevent and fight disease. In this Lightning Talk, two brothers at UTSW Medical Center —one an Infectious Disease expert trained at NIH, the other a Johns Hopkins-trained Neuroimmunologist—are on separate but driven paths.

Meet Dr. David Greenberg who is focused on commercializing precision pathogen-specific antibiotics to help tackle the worldwide crisis of antibiotic resistance. And learn about Dr. Ben Greenberg’s efforts for the Department of Neurology in treating rare autoimmune disorders of the central nervous system.